Cardiol Therapeutics Inc T.CRDL.W.A

Primary Symbol: T.CRDL Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > Bought Deal with Raymond James

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon May 06, 2021 1:41am

151 Views

Post# 33138634

RE:Bought Deal with Raymond James

Damn Cdn. co.s keep falling for BS of underwriters and financial advisors that equity issues must include warrants. Other co.s do share-only PPs:

Acst	Erth	OPS	Tsk
Aezs	Eva	PBIC	Upco
Bhsc	Exro	PHA	Vhi
Blu	Food	PKT	VXTR
Boy	FTRP	PLCO
Bti	Gra	PNG
Bzi	Halo	Popr
CCHW	Huge	Ptq
CGY	ID	QUIS
Cps	IMP	Rmmi
Crrx	IVI	Rti
Cts	Khrn	Scr
CUB	KUU	Sev
Dcsi	MDF	Shg
Dose	Mile	Sire
Eglx	Mrgo	Sis
	Mvp	STC
	NNO
	NOU